Armata Pharmaceuticals Inc (ARMP)
2.10
+0.01
(+0.48%)
USD |
NYAM |
Nov 21, 16:00
2.10
0.00 (0.00%)
After-Hours: 20:00
Armata Pharmaceuticals Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.0313 |
| June 30, 2017 | 0.0615 |
| March 31, 2017 | 0.09 |
| December 31, 2016 | 0.0826 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| Date | Value |
|---|---|
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
| December 31, 2013 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| AIM ImmunoTech Inc | 0.9382 |
| Perspective Therapeutics Inc | -- |
| Protalix BioTherapeutics Inc | 0.00 |
| Electromed Inc | 0.00 |
| Xtant Medical Holdings Inc | 0.7605 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 98.24M |
| Total Liabilities (Quarterly) | 149.21M |
| Shareholders Equity (Quarterly) | -50.97M |